Clinical Research Directory
Browse clinical research sites, groups, and studies.
Methotrexate and Metformin in Rheumatoid Arthritis Patients
Sponsor: University Hospital, Bordeaux
Summary
Methotrexate (MTX) is the anchor drug for patients with rheumatoid arthritis (RA). Despite its marked efficacy and acceptable side effect profile, about 1/3 of patients failed to reach RA remission. Metformin is the first-line therapy for type 2 diabetes. Its antioxidative and anti-inflammatory properties make it a good candidate for the treatment of inflammatory diseases such as rheumatoid arthritis.
Official title: Randomized Placebo-controlled Trial Comparing Methotrexate vs. Methotrexate/Metformin Association in Rheumatoid Arthritis Patients
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
128
Start Date
2020-12-03
Completion Date
2026-06
Last Updated
2026-02-03
Healthy Volunteers
No
Conditions
Interventions
Metformin treatment
1500 mg once a day, per os, during six months
Placebo
per os, during six months
Methotrexate treatment
per os
Locations (12)
CH de la Côte Basque - service de rhumatologie
Bayonne, France
CHU de Bordeaux - service de rhumatologie
Bordeaux, France
CHU de Brest - service de rhumatologie
Brest, France
CH de Cahors - service de rhumatologie
Cahors, France
Clinique de l'Infirmerie protestante de Lyon - service de rhumatologie
Caluire-et-Cuire, France
CHD de Vendée - service de rhumatologie
La Roche-sur-Yon, France
CH du Mans - service de rhumatologie
Le Mans, France
CH de Libourne - service de rhumatologie
Libourne, France
CHU de Montpellier - service de rhumatologie
Montpellier, France
CHR Orléans la Source - service de rhumatologie
Orléans, France
CH de Pau - service de rhumatologie
Pau, France
CHU de Toulouse - service de rhumatolgie
Toulouse, France